
Episode 11: Investors
Bad Blood: The Final Chapter
Thernos - Theronos vs Fizer
Tolbert testified that thernos had generated significant cash from its contrac with pharmasutical companies. We now know from the evidence presented at trial that this wasn't true. Theranos had lost money every single year its existence. By the end of two thousand 13, when this call took place, the company had accumulated losses of 253 million dollars.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.